Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular ozone versus triamcinolone for chronic ankle osteoarthritis
IRCT20100827004641N19Phase 3Completed
- Sponsor
- Physical Medicine and Rehabilitation Research Center
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of medical ozonated water and triamcinolone in ankle osteoarthritis (2 arms), sponsored by Physical Medicine and Rehabilitation Research Center. Primary endpoints: Ankle function and Pain. Started Nov 2019; status: completed.
02
Drugs
medical ozonated watertriamcinolone
03
Conditions
ankle osteoarthritis
Beyond the preview
Go deeper on IRCT20100827004641N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100827004641N19.